Association of Asymmetric Dimethylarginine and Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
13 07 2019
Historique:
received: 07 06 2019
revised: 11 07 2019
accepted: 11 07 2019
entrez: 25 7 2019
pubmed: 25 7 2019
medline: 9 4 2020
Statut: epublish

Résumé

Despite genetic heterogeneity, early manifestation of diastolic dysfunction (DD) is common in hypertrophic cardiomyopathy (HCM). Nitric oxide (NO) may contribute to myocardial relaxation. NO synthases (NOS) use l-arginine (Arg) as a substrate, as asymmetric dimethylarginine (ADMA) is a direct endogenous inhibitor of NOS. This study aimed to analyze the association of Arg and its derivates, i.e., l-homoarginine (hArg), ADMA and symmetric dimethylarginine (SDMA), with DD in HCM patients. In 215 HCM patients (mean age 54 ± 15 years, 58% male) transmitral and mitral annulus velocities were echocardiographically analyzed. Plasma concentrations of Arg derivatives were measured by liquid chromatography tandem-mass spectrometry. In 143 (70%) patients suffering from DD, ADMA showed the strongest association with DD (0.66 ± 0.16, 0.72 ± 0.24, and 0.76 ± 0.26 µmol/L,

Identifiants

pubmed: 31337005
pii: biom9070277
doi: 10.3390/biom9070277
pmc: PMC6681289
pii:
doi:

Substances chimiques

N,N-dimethylarginine 63CV1GEK3Y
Arginine 94ZLA3W45F
Nitric Oxide Synthase EC 1.14.13.39

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Annu Rev Biochem. 1994;63:175-95
pubmed: 7526779
Am J Physiol. 1994 Nov;267(5 Pt 2):H1804-13
pubmed: 7526713
Pharmacol Ther. 2000 Apr;86(1):49-86
pubmed: 10760546
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Aug 1;879(23):2294-8
pubmed: 21737361
Curr Opin Clin Nutr Metab Care. 2015 Jan;18(1):83-8
pubmed: 25474016
J Am Coll Cardiol. 2018 Aug 14;72(7):721-733
pubmed: 30092948
Eur Heart J Cardiovasc Imaging. 2017 Dec 1;18(12):1414-1422
pubmed: 28165128
Nitric Oxide. 2016 Apr 1;54:73-81
pubmed: 26923818
Nitric Oxide. 1997 Feb;1(1):65-73
pubmed: 9701046
PLoS One. 2015 Aug 27;10(8):e0135498
pubmed: 26313940
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 May 15;851(1-2):211-9
pubmed: 17194630
Am J Physiol Heart Circ Physiol. 2015 Jun 1;308(11):H1351-8
pubmed: 25795712
Int J Rheum Dis. 2017 Feb;20(2):238-244
pubmed: 26012572
Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):1846-58
pubmed: 9351345
Eur J Heart Fail. 2011 Aug;13(8):852-9
pubmed: 21791541
Eur Heart J. 2008 Oct;29(20):2506-13
pubmed: 18687662
Am J Physiol. 1994 May;266(5 Pt 2):H1699-705
pubmed: 8203569
Circulation. 2013 Sep 24;128(13):1451-61
pubmed: 24004504
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
pubmed: 16376782
Int J Cardiol. 2016 Jan 15;203:640-6
pubmed: 26580348
Circulation. 2006 Jul 4;114(1 Suppl):I16-20
pubmed: 16820567
Biomolecules. 2018 Aug 30;8(3):
pubmed: 30200232
Europace. 2016 Nov;18(11):1609-1678
pubmed: 27567465
J Card Fail. 2014 Dec;20(12):923-30
pubmed: 25230239
Nature. 1988 Jun 16;333(6174):664-6
pubmed: 3131684
Kidney Int. 2002 Jul;62(1):339-45
pubmed: 12081596
J Am Heart Assoc. 2016 Apr 13;5(4):e002565
pubmed: 27076564
Biochemistry. 1998 Jul 21;37(29):10453-60
pubmed: 9671515
Eur J Echocardiogr. 2009 Mar;10(2):165-93
pubmed: 19270053
Sci Rep. 2018 Feb 27;8(1):3697
pubmed: 29487337
Eur Heart J. 2014 Oct 14;35(39):2733-79
pubmed: 25173338
Biomed Res Int. 2015;2015:762950
pubmed: 26881205
Lancet. 1992 Mar 7;339(8793):572-5
pubmed: 1347093
Am Heart J. 2016 Jun;176:100-6
pubmed: 27264226
Circulation. 1994 May;89(5):2070-8
pubmed: 7910117

Auteurs

Kathrin Cordts (K)

Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
DZHK (German Centre of Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.

Doreen Seelig (D)

Clinic of General and Interventional Cardiology, University Heart Center, 20246 Hamburg, Germany.

Natalie Lund (N)

Clinic of General and Interventional Cardiology, University Heart Center, 20246 Hamburg, Germany.

Lucie Carrier (L)

Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
DZHK (German Centre of Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.

Rainer H Böger (RH)

Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
DZHK (German Centre of Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.

Maxim Avanesov (M)

Clinic of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Enver Tahir (E)

Clinic of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Edzard Schwedhelm (E)

Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
DZHK (German Centre of Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.

Monica Patten (M)

Clinic of General and Interventional Cardiology, University Heart Center, 20246 Hamburg, Germany. patten@uke.de.
DZHK (German Centre of Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany. patten@uke.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH